S799 Health-Related Quality of Life with Guselkumab Induction and Maintenance Therapy as Measured by PROMIS-29: Results Through Week 48 of Phase 2 GALAXI 1 Study
العنوان: | S799 Health-Related Quality of Life with Guselkumab Induction and Maintenance Therapy as Measured by PROMIS-29: Results Through Week 48 of Phase 2 GALAXI 1 Study |
---|---|
المؤلفون: | David T. Rubin, Bruce E. Sands, Remo Panaccione, Chenglong Han, Kathleen Weisel, Mary Ellen Frustaci, Zijiang Yang, Aparna Sahoo, Anita Afzali, Jane Andrews, Silvio Danese, Tadakazu Hisamatsu, Brian G. Feagan, Julian Panés, Walter Reinisch, William J. Sandborn, Geert D’Haens |
المصدر: | American Journal of Gastroenterology. 117:e569-e570 |
بيانات النشر: | Ovid Technologies (Wolters Kluwer Health), 2022. |
سنة النشر: | 2022 |
مصطلحات موضوعية: | Hepatology, Gastroenterology |
تدمد: | 1572-0241 0002-9270 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::af5585316e2b47218edf9aa63834f98e https://doi.org/10.14309/01.ajg.0000859836.33457.73 |
رقم الأكسشن: | edsair.doi...........af5585316e2b47218edf9aa63834f98e |
قاعدة البيانات: | OpenAIRE |
تدمد: | 15720241 00029270 |
---|